The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Clinicopathological Correlations of Parkinson’s Disease, 2009Identification of Alpha-synuclein Molecular Forms Correlating with Clinicopathology of Parkinson's Disease
Objective/Rationale:
A systematic characterization of alpha-synuclein from human tissue using high-resolution mass spectrometry has not been reported. A detailed study of alpha synuclein modifications... -
Clinicopathological Correlations of Parkinson’s Disease, 2009miRNAs as new therapeutic targets and diagnostic biomarkers of PD
Objective/Rationale:
microRNAs are newly recognized, small regulatory molecules, playing important roles in normal functions and disease. However, their roles in Parkinson’s disease are still largely... -
Prescott Family Initiative at the Arizona Parkinson's Diseas, 2009Arizona Parkinson's Disease Consortium: Predictors of Parkinson’s Disease and Parkinson’s Disease-Dementia
Promising Outcomes of Original Grant:
The goals of the original grant were to expand the number of PD patients enrolled, incorporate new questionnaires for recording non-motor manifestations of PD... -
MJFF Research Grant, 2009Validation of Dyskinesia Rating Scales
Objective/Rationale:
Dyskinesias, or involuntary jerking movements, are troublesome problems for many Parkinson’s disease patients. Chemical studies have led to the development of several new... -
Rapid Response Innovation Awards, 2009Plasma Biomarker Screen for Neurodegeneration and Signaling Proteins
Objective/Rationale:
The cells and tissues of the body can “communicate” with one another using small secreted proteins that can be found in the blood. There are several hundred of these cellular... -
Rapid Response Innovation Awards, 2009Oligomeric Equilibrium in Male and Female Brains with Alpha-synuclein Pathology
Objective/Rationale:
Men are more susceptible to Parkinson's disease than women. Alpha-synuclein aggregates are a hallmark of the disease and it is increasingly believed that alpha-synuclein...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.